Document is current
Any future updates will be listed below
-
Authors
Coles, Theresa M. http://orcid.org/0000-0003-2941-8999
Hernandez, Adrian F.
Reeve, Bryce B.
Cook, Karon
Edwards, Michael C.
Boutin, Marc
Bush, Elizabeth
Degboe, Arnold
Roessig, Lothar
Rudolph, Amy
McNulty, Pauline
Patel, Nikunj
Kay-Mugford, Trish
Vernon, Margaret
Woloschak, Michael
Buchele, Gustavo
Spertus, John A.
Roe, Matthew T.
Bury, Denise
Weinfurt, Kevin
-
Funding
Funding for this research was provided by:
Duke Clinical Research Institute
- License Information
-
More Information
Article History
Received: 10 March 2021
Accepted: 8 June 2021
First Online: 13 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: TMC reports contracts from FDA and Merck. AFH reports personal fees from Amgen, grants and personal fees from AstraZeneca, personal fees from Boston Scientific, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Bayer, personal fees from Cytokinetics, grants from American Regent, personal fees from Myokardia, personal fees from Eidos, personal fees from Intercept, grants and personal fees from Merck, grants and personal fees from Novartis, personal fees from Relypsa, and grants from Verily. MB reports support from National Health Council Members and Sponsors; the National Health Council membership listing is available at: ExternalRef removed. EB is an employee and shareholder of Eli Lilly and Company. AD is a full-time employee of AstraZeneca. LR is an employee of Bayer AG. AR is an employee of Novartis. PM is an employee of Janssen and owns stock in Johnson & Johnson. NP is an employee of AstraZeneca. TK-M is an employee of Novartis. MV is an employee of Evidera. MW is an employee of Sanofi. GB is an employee of Ionis Pharmaceuticals. No other disclosures were reported.
